uploads/2018/09/hospital-3098683_1280.jpg

Boston Scientific Stock in the Week Ended September 14

By

Updated

Boston Scientific’s trading activity this week

Today, Boston Scientific (BSX) stock opened at $37.43, a decline of ~0.51% compared to yesterday’s closing price of $37.62. Yesterday, the stock was trading at its 52-week high as well as at its highest price since October 2004. BSX stock is trading ~53.0% higher than its 52-week low of $24.54 reported on December 6, 2017.

Over the last week, BSX stock has risen ~4.5%. The stock has been gaining new highs while it has been riding in bullish territory over the last year. BSX stock has risen ~11.6% over the last month. Year-to-date, BSX stock has reported stellar gains of ~52.0%. The one-year stock price return for BSX stands at ~30%. As of September 14, Boston Scientific stock’s 50-day moving average is $34.64, and its 200-day moving average is $31.23.

Peers Abbott Laboratories (ABT), Medtronic (MDT), and Edwards Lifesciences (EW) have returned 4.1%, 0.48%, and 3.8% over the last week.

Article continues below advertisement

Major events that triggered Boston Scientific’s recent stock performance

As Market Realist reported on September 13, Boston Scientific was up ~3.2% yesterday on the increased organic sales growth guidance for 2019–2020. This development was announced during its presentation at Morgan Stanley Healthcare Conference on September 13.

Over the last week, Boston Scientific stock has been rising, triggered by several positive analysts’ recommendation updates. These updates followed the announcement of Boston Scientific’s acquisition of Augmentix on September 7. We’ll discuss these events in detail in the next few articles in this series.

BSX stock had already been garnering positive analysts’ views and recommendations in early September. The increase in Boston Scientific’s target price by Jefferies and Raymond James on September 4 led to positive investor sentiment. This trend triggered a stock price rise of ~1.4% on the day.

Be sure to check out all the data we’ve added to our quote pages. Now you can get a valuation snapshot, earnings and revenue estimates, and historical data, as well as dividend information. Take a look!

Advertisement

More From Market Realist